Proactive news highlights: Anglo Pacific, e-Therapeutics, Eurasia mining, Forbidden Technologies and more

Graphene NanoChem receives an order for its oilfield recovery additive, e-Therapeutics tells investors that it remains well funded and Forbidden Technology partners with an energy drink.

A big pile of news
Daily news round-up from the world of Proactive

Asiamet Resources Limited (LON:ARS, CVE:ARS) kicked off a 9,000m resource definition drill programme at the Beruang Kanan Main copper project in Indonesia with a view to posting an updated estimate before the end of the third quarter of 2016.

It follows a positive preliminary economic assessment for the copper project and is part of the feasibility study process.

In other news, financial results from CentralNic Group Plc (LON:CNIC) showed the web domains group continued to add scale to its business, something that will be further boosted by the recent acquisition of Instra Group, which was acquired in January. The deal is seen as ‘transformational’ by chairman Mike Turner.

Over at Eurasia Mining (LON:EUA), it farmed out the mining of its West Kytlim alluvial platinum deposit in the Urals to local Russian firm SKRS. The firm will be responsible for construction and processing ore from the Malaya Sosnovka sub-area at West Kytlim in return for a 70% share of revenue.

Mining royalty specialist Anglo Pacific Group plc (LON:APF TSX:APY) expects income this year to be well ahead of 2015 as coking coal prices have started to recover.

Royalties in the first quarter to March dropped to £1.9mln (£2.3mln) but, like 2015, income is expected to be heavily weighted towards the second half of the year said Julian Treger, chief executive.

Elsewhere, Graphene NanoChem (LON:GRPH)  received a firm order for PlatSurF, its oilfield recovery additive, for a 16 - 18 wells drilling programme in Myanmar.

It is the company’s first contract in Myanmar with the initial four well order worth just under US$200,000.

Meanwhile, FairFX Group Plc (LON:FFX) said the commercial momentum reported at the last update had continued.

The most recent week was a record for the year, with turnover at levels not seen since last July. Retail card loads and spending are both running ahead of 2015.

Over at e-Therapeutics plc (LON:ETX), the drug discoverer told the AGM today that it remained well funded and focused on commercialisation of compounds created by its proprietary drug discovery platform.

The two most advanced discovery compounds are approaching lead candidate selection with the expectation that the most advanced will enter preclinical development in the coming months, the group said.

And finally, Forbidden Technologies plc (LON:FBT) agreed a new channel deal for social media platform eva  with Rich Energy, a new energy drink brand.

Rich Energy will use eva to record user-generated video content in a private channel that is due for public release at the start of June.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of e-Therapeutics PLC named herein, including the promotion by the Company of e-Therapeutics PLC in any Content on the Site, the Company receives...



Australian Vanadium confirms ‘exceptional’ vanadium extraction in test work

Australian Vanadium Ltd (ASX:AVL) (OTCMKTS:ATVVF) managing director Vincent Algar speaks to Proactive about recent pilot test-work conducted at the Australian Vanadium Project, which delivered leach extraction of up to 94.7%. The pilot-scale roast and leach testing has confirmed the...

3 days, 5 hours ago

3 min read